期刊
BIOMATERIALS
卷 270, 期 -, 页码 -出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2020.120649
关键词
Glutathione response; Multidrug resistance; poly(disulfide)
资金
- National Natural Science Foundation of China [51873072, 52073101]
- Guangdong Provincial Pearl River Talents Program [2019QN01Y088]
- Science and Technology Program of Guangzhou [201804020060]
- Outstanding Scholar Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory [2018GZR110102001]
- Fundamental Research Funds for the Central Universities
This study introduces a polyprodrug (PSSD) that can deplete GSH and activate drugs simultaneously, aiming to reverse multidrug resistance. The poly(disulfide) backbone depletes GSH and triggers the activation of DOX through a cascade reaction, showing promising potential in overcoming drug resistance.
High intracellular glutathione (GSH) levels play an important role in multidrug resistance (MDR) in cancer cells. It remains challenging to develop a drug delivery system that is simultaneously capable of GSH depletion and drug activation for multidrug resistance reversal. Herein, we designed a polyprodrug (denoted as PSSD) based on poly(disulfide) conjugated with doxorubicin (DOX) on the polymer side chains that exhibits GSH depletion and cascade DOX activation for drug resistance reversal. The poly(disulfide) backbone with a high disulfide density depletes intracellular antioxidant GSH via the disulfide-thiol exchange reaction to disrupt intracellular redox homeostasis in cells. Simultaneously, DOX can be activated through a cascade reaction, and degradation of the poly(disulfide) backbone further facilitates its drug release. Therefore, poly(disulfide) can be used as a GSH scavenger to reverse MDR as well as a prodrug backbone to target high intracellular GSH levels in cancer cells, providing a general strategy for drug resistance reversal.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据